热门资讯> 正文

Fortress Biotech第二季度盈利预览

2026-08-12 05:35

Fortress Biotech (FBIO) is scheduled to announce Q2 earnings results on Wednesday, August 12th, after market close.
The consensus EPS Estimate is -$0.20 and the consensus Revenue Estimate is $18.3M (+11.5% Y/Y).

More on Fortress Biotech

Fortress Biotech Just Netted $159 Million - Its Preferred Shares Could Be The Real Winner
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
Seeking Alpha’s Quant Rating on Fortress Biotech

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。